Preclinical Evaluation of [18F]ML-10 to Assessment of Radioimmunotherapy with [177Lu]Lu-Labeled Antibody

被引：0
|
作者：
Lee, S. [1 ]
Ko, N. [1 ]
Cho, E. [1 ]
Chung, J. [2 ]
Kim, S. [2 ]
Lim, S. [1 ]
Oh, S. [1 ]
机构：
[1] ASAN Med Ctr, Seoul, South Korea
[2] Asan Inst Life Sci, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0915
引用
收藏
页码：S673 / S673
页数：1
相关论文
共 50 条
  • [21] Design and synthesis of a new bifunctional chelating agent: Application for Al 18F/177Lu complexation
    Laurene, Wagner
    Raul, Losantos
    Katalin, Selmeczi
    Celine, Frochot
    Gilles, Karcher
    Antonio, Monari
    Charlotte, Collet
    Samir, Acherar
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2023, 246
  • [22] Preclinical Evaluation of [18F]F-[natLu]Lu-/[19F]F-[177Lu]Lu DOTA-rhCCK-18, a Radiohybrid-Based Minigastrin Analog With High Target Affinity and Tumor Accumulation: First Steps Towards Clinical Translation
    Holzleitner, N.
    Guenther, T.
    Greifenstein, L.
    Urtz-Urban, N.
    Di Carlo, D.
    Lapa, C.
    Baum, R.
    Wester, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S281 - S282
  • [23] Performance Evaluation of a New Collimator Optimized for 177Lu Preclinical SPECT Imaging
    Colpo, N.
    Uribe, C.
    Rousseau, J.
    Kamphuis, C.
    Beekman, F.
    Benard, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S873 - S874
  • [24] Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer
    Wen-Ting K Tsai
    Kirstin A Zettlitz
    Magnus Dahlbom
    Robert E Reiter
    Anna M Wu
    Molecular Imaging and Biology, 2020, 22 : 1380 - 1391
  • [25] Development and preclinical evaluation of novel 177Lu-labelled radiohybrid CCK-2R-targeted ligands based on [177Lu]Lu-DOTA-PP-F11N
    Holzleitner, N.
    Guenther, T.
    Lapa, C.
    Wester, H. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S143 - S144
  • [26] Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer
    Tsai, Wen-Ting K.
    Zettlitz, Kirstin A.
    Dahlbom, Magnus
    Reiter, Robert E.
    Wu, Anna M.
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (05) : 1380 - 1391
  • [27] Chlorambucil Conjugation Enhances the Potency of Rituximab: Synthesis and Evaluation of the Novel [177Lu]Lu-Labeled Rituximab-Chlorambucil Conjugate toward Therapy of Non-Hodgkin's Lymphoma
    Kumar, Naveen
    Suman, Shishu Kant
    Guleria, Mohini
    Kolay, Soumi
    Amirdhanayagam, Jeyachitra
    Chakraborty, Avik
    Rakshit, Sutapa
    Mukherjee, Archana
    Das, Tapas
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1365 - 1381
  • [28] In vitro and in vivo evaluation of a novel anti-EGFR antibody labeled with 89Zr and 177Lu
    Liu, Wei
    Li, Kehong
    Deng, Hao
    Wang, Jing
    Zhao, Peng
    Liao, Wei
    Zhuo, Liangang
    Wei, Hongyuan
    Yang, Xia
    Chen, Yue
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2022, 331 (02) : 747 - 754
  • [29] Implementation of an 18F PET / 177Lu SPECT Phantom Study for Personalized Theranostics in PSMA Radiopharmaceutical Therapies
    Fedrigo, R.
    Tran-Gia, J.
    Brosch-Lenz, J.
    Petric, P.
    Fougner, L.
    Sabo, K.
    Ralea, R.
    Harsini, S.
    Bloise, I.
    Beauregard, J.
    Benard, F.
    Rahmim, A.
    Uribe, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S368 - S369
  • [30] Preparation and biological evaluation of 177Lu conjugated PR81 for radioimmunotherapy of breast cancer
    Salouti, Mojtaba
    Babaei, Mohammad Hossein
    Rajabi, Hossein
    Rasaee, Mohammad Javad
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (06) : 849 - 855
12345